Minkonti 50 mg tablete s produljenim oslobađanjem
| Name | Minkonti 50 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-086064749 |
| Active Substance | mirabegron |
| Composition | svaka tableta sadrži 50 mg mirabegrona |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | AdAlvo Limited, San Gwann, Malta
Pharmadox Healthcare Limited, Paola, Malta |
| Marketing Authorisation Holder | Teva GmbH, Graf-Arco-Strasse 3, Ulm, Njemačka |
| Marketing Authorisation Date | 30.07.2024 |
| MA Period of Validity | 30.07.2029 |
| Classification Number | UP/I-530-09/23-01/377 |
| Registration Number | 381-12-01/286-24-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD12 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
